OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
25 hedge funds and large institutions have $3.86M invested in OncoSec Medical Incorporated in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 4 closing their positions.
11% less funds holding
Funds holding: 28 → 25 (-3)
37% less capital invested
Capital invested by funds: $6.09M → $3.86M (-$2.23M)
50% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 8
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$20.9K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.6K |
| 3 |
VVP
Venture Visionary Partners
Sylvania,
Ohio
|
+$1.3K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$671 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$19 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$43.7K |
| 2 |
DADC
D.A. Davidson & Co
Great Falls,
Montana
|
-$31.8K |
| 3 |
VF
Virtu Financial
New York
|
-$18K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFEC
26
Benjamin F. Edwards & Company
St. Louis,
Missouri
| – | -$1K | -45 | Closed |
|
27
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -15 | Closed |
|
|
28
Wells Fargo
San Francisco,
California
| – | +$19 | +1 | +20% |
|
ONCS Hedge Fund Activity: Q2 2022 in Review
25 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2022, worth a combined $3.86M — down 37% from $6.09M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ONCS and 1 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $20.9K. The largest seller was BlackRock, cutting an estimated $43.7K.
- 25 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2022, down from 28 in Q1 2022.
- Funds reported $3.86M of OncoSec Medical Incorporated stock for Q2 2022, down 37% quarter-over-quarter.
- 1 fund opened new OncoSec Medical Incorporated positions in Q2 2022 and 4 closed out, a net change of -3 holders.
- The largest OncoSec Medical Incorporated buyer in Q2 2022 was Renaissance Technologies, an estimated $20.9K added.
- The largest OncoSec Medical Incorporated seller in Q2 2022 was BlackRock, an estimated $43.7K sold.
Based on aggregated 13F filings for Q2 2022.